Advertisement

Congenital Cytomegalovirus Infection: Epidemiology and Treatment

  • Richard J. Whitley
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 549)

Abstract

Cytomegalovirus (CMV) is the most common cause of congenital virus infection worldwide, occurring in approximately 1% of all live borns with a prevalence ranging from 0.2% to 2.2% (Stagno et al., 1983). Congenital infection is the consequence of transplacental transfer of virus from mother to fetus. Maternal infection can either be primary or recurrent. Maternal primary infection usually results from contact with a young child in the day care environment (Demmler, 1994). Women working at day care centers, nursery schools, or preschools have an increased risk for acquisition of CMV, if seronegative (Adler, 1989). In such circumstances, the rate of acquisition can be 8%–20% as compared to 3%–5% for the general population (Pass et al., 1986, 1990; Adler, 1989; Murph et al., 1991; Alder et al., 1996). In adolescents and young adults, persistent excretion of CMV in saliva, cervical secretions, and semen incriminates sexual transmission as a mode of infection. Demographic factors, including urban residence, ethnicity, and socioeconomic status, influence the rate of acquisition of CMV. For middle and upper socioeconomic individuals, adults have seropositivity rate of 40%–60% as compared to those of lower socioeconomic status where seropositivity varies between 80%–100%. Similarly, higher rates of CMV seropositivity exist in developing countries (Griffiths and Baboonian, 1984; Ashraf et al., 1985; Wang and Evans, 1986; Yow et al., 1988; Demmler, 1994; Troendle-Atkins et al., 1994).

Keywords

Sensorineural Hearing Loss Cytomegalovirus Infection Congenital Infection Ganciclovir Therapy Congenital Cytomegalovirus Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adler, S.P. (1989). Cytomegalovirus and child day care. Evidence for an increased infection rate among day-care workers. N. Engl. J. Med. 321, 1290–1296.PubMedCrossRefGoogle Scholar
  2. Adler, S.P., Finney, J.W., Manganello, A.M., and Best, A.M. (1996). Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: A randomized controlled trial. Pediatr. Infect. Dis. J. 15, 240–246.PubMedCrossRefGoogle Scholar
  3. Ashraf, S.J., Parande, C.M., and Arya, S.C. (1985). Cytomegalovirus antibodies of patients in the Gizan area of Saudi Arabia. J. Infect. Dis. 152, 1351.PubMedCrossRefGoogle Scholar
  4. Boppana, S.B., Pass, R.F., Britt, W.J., Stagno, S., and Alford, C.A. (1992). Symptomatic congenital cytomegalovirus infection: Neonatal morbidity and mortality. Pediatr. Infect. Dis. J. 11, 93–99.PubMedCrossRefGoogle Scholar
  5. Demmler, G.J. (1991). Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev. Infect. Dis. 13, 315–329.PubMedCrossRefGoogle Scholar
  6. Demmler, G.J. (1994). Congenital cytomegalovirus infection. Semin. Pediatr. Neurol. 1, 36–42.PubMedGoogle Scholar
  7. Fowler, K., Stagno, S., and Pass, R. (1993). Maternal age and congenital cytomegalovirus infection: Screening of two diverse newborn populations, 1980-1990. J. Infect. Dis. 168, 552–556.PubMedCrossRefGoogle Scholar
  8. Fowler, K.B., Stagno, S., Pass, R.F., Britt, W.J., Boll, T.J., and Alford, C.A. (1992). The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N. Engl. J. Med. 326, 663–667.PubMedCrossRefGoogle Scholar
  9. Griffiths, P.D. and Baboonian, C. (1984). A prospective study of primary cytomegalovirus infection during pregnancy: Final report. Br. J. Obstet. Gynecol. 91, 307–315.CrossRefGoogle Scholar
  10. Hoffman-La Roche, I. Ganciclovir Package insert. Nutley, N. J. (1989). Cytovene(r)-IV and Cytovene(r) Capsules. IHMF Monograph. (1999). Herpesvirus infections in pregnancy. Management Strategies Workshop and 7th Annual Meeting, Seville, Spain.Google Scholar
  11. Kimberlin, D.W., Lin, C.-Y, Sanchez, P.J., Demmler, G.J., Dankner, W., Shelton, M.D. et al., and the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. (2003). Effect of ganciclovir on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: A randomized, controlled trial. J. Pediatr. 143, 16–25.PubMedCrossRefGoogle Scholar
  12. Marcy, S.M. and Wald, E.R. (2003). Management of acute otitis media. Pediatr. Infect. Dis. J. 22, 673–674.PubMedGoogle Scholar
  13. Murph, J.R., Baron, J.C., Brown, K.C., Ebelhack, C.L., and Bale, J.F., Jr. (1991). The occupational risk of cytomegalovirus infection among day care providers. JAMA 265, 603–608.PubMedCrossRefGoogle Scholar
  14. Nigro, G., Scholz, H., and Bartmann, U. (1994). Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: A two-regimen experience. J. Pediatr. 124, 318–322.PubMedCrossRefGoogle Scholar
  15. Pass, R.F., Hutto, C., Lyon, M.D., and Cloud, G. (1990). Increased rate of cytomegalovirus infection among day care center workers. Pediatr. Infect. Dis. J. 9, 465–470.PubMedCrossRefGoogle Scholar
  16. Pass, R.F., Hutto, S.C., Ricks, R., and Cloud, G.A. (1986). Increased rate of cytomegalovirus infection among parents of children attending day care centers. N. Engl. J. Med. 314, 1414–1418.PubMedCrossRefGoogle Scholar
  17. Stagno, S. (1986). Primary cytomegalovirus infection in pregnancy: Incidence, transmission to fetus and clinical outcome in two populations of different socioeconomic backgrounds. JAMA 256, 1904–1908.PubMedCrossRefGoogle Scholar
  18. Stagno, S., Pass, R.F., Dworsky, M.E., and Alford, C.A. (1982). Maternal cytomegalovirus infection and perinatal transmission. Clin. Obstet. Gynecol. 25, 563–576.PubMedCrossRefGoogle Scholar
  19. Stagno, S., Pass, R.F., Dworsky, M.E., and Alford, C.A. (1983). Congenital and perinatal cytomegalovirus infections. Semin. Perinatal. 7, 31–42.Google Scholar
  20. Trang, J.M., Kidd, L., Gruber, W., Storch, G., Demmler, G., Jacobs, R. et al., and the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. (1993). Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. Clin. Pharmacol. Ther. 53, 15–21.PubMedCrossRefGoogle Scholar
  21. Troendle-Atkins, J., Demmler, G.J., Williamson, W.D., McDonald, J.M., Istas, A.S., and Buffone, G.J. (1994). Polymerase chain reaction to detect cytomegalovirus DNA in the cerebrospinal fluid of neonates with congenital infection. J. Infect. Dis. 169, 1334–1337.PubMedCrossRefGoogle Scholar
  22. Wang, P.S. and Evans, A.S. (1986). Prevalence of antibodies to Epstein-Barr virus and cytomegalovirus in sera from a group of children in the People’s Republic of China. J. Infect. Dis. 153, 150–152.PubMedCrossRefGoogle Scholar
  23. Whitley, R.J., Cloud, G., Gruber, W., Storch, G.A., Demmler, G.J., Jacobs, R.E et al., and National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. (1997). Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: Results of a phase II Study. J. Infect. Dis. 175, 1080–1086.PubMedCrossRefGoogle Scholar
  24. Yow, M.D. and Demmler, G.J. (1992). Congenital cytomegalovirus disease: 20 years is long enough. N. Engl. J. Med. 326, 702–703.PubMedCrossRefGoogle Scholar
  25. Yow, M.D., Williamson, D.W., Leeds, L.J., Thompson, P., Woodward, R.M., Walmus, B.F. et al. (1988). Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants. Am. J. Obstet. Gynecol. 58, 1189–1195.Google Scholar
  26. Zhou, X.-J., Gruber, W., Demmler, G., Jacobs, R., Reuman, P., Adler, S. et al., and National Institute of Allergy and Infectious Disease Collaborative Antiviral Study Group. (1996). Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. Antimicrob. Agents Chemother. 40, 2202–2205.PubMedGoogle Scholar

Copyright information

© Science+Business Media New York 2004

Authors and Affiliations

  • Richard J. Whitley

There are no affiliations available

Personalised recommendations